Filing metadata

Accession number
0000899243-21-040250
Form type
Form 3
Filer
Spero Therapeutics, Inc.
CIK
CIK 1701108
Filed
Oct 14, 2021
Reporting period
Oct 11, 2021
Description
Initial ownership

Explore SEC Filings Hub